FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy

por Day, F L, Link, E, Ngan, S, Leong, T, Moodie, K, Lynch, C, Michael, M, Winton, E de, Hogg, A, Hicks, R J, Heriot, A
Publicado 2011

Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer

por Day, F L, Leong, T, Ngan, S, Thomas, R, Jefford, M, Zalcberg, J R, Rischin, D, McKendick, J, Milner, A D, Di Iulio, J, Matera, A, Michael, M
Publicado 2011